Research Papers

7 of 107 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Clinical characteristics and unlicensed applications of licensed psychotropic drugs within a regional tertiary service …
Tiwari N; Baldwin DS.
Ther Adv Psychopharmacol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- …
Veznedaroglu B; Dilbaz N; Uzun O; Isik E.
Ther Adv Psychopharmacol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment.
Litwin T; Dusek P; Szafrański T; Dzieżyc K; Członkowska A; Rybakowski JK.
Ther Adv Psychopharmacol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
A prospective year-long follow-up of lurasidone use in clinical practice: factors predicting treatment persistence.
Osborne IJ; Mace S; Taylor D.
Ther Adv Psychopharmacol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Treatment response, safety, and tolerability of paliperidone extended release treatment in patients recently diagnosed …
Helldin L; Peuskens J; Vauth R; Sacchetti E; Bij de Weg H; Herken H; Lahaye M; Schreiner A.
Ther Adv Psychopharmacol (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Use of quetiapine XR and quetiapine IR in clinical practice for hospitalized patients with schizophrenia: a retrospecti…
Eriksson L; Hallerbäck T; Jørgensen L; Carlborg A.
Ther Adv Psychopharmacol (Unknown)
Published: 2012
3/6 Transparent
Registered Funding Declared
Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophren…
Bossie CA; Fu DJ; Sliwa JK; Ma YW; Alphs L.
Ther Adv Psychopharmacol (Unknown)
Published: 2011
3/6 Transparent
Registered Funding Declared